Basic psychopharmacology of antidepressants, Part 2: Estrogen as an adjunct to antidepressant treatment

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL.4, 1998, Pages 15-24

  Stahl, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CATECHOLAMINE; ESTROGEN; PROGESTERONE; SEROTONIN; STEROID;

AFFECTIVE NEUROSIS; DEPRESSION; ESTROGEN BLOOD LEVEL; FEMALE; HORMONAL THERAPY; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; MENTAL HEALTH; MOOD; NEUROTRANSMISSION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PSYCHIATRIC DIAGNOSIS; RECURRENT DISEASE; REVIEW; TREATMENT PLANNING;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; MOOD DISORDERS; PHYSICIAN'S ROLE; PROGESTERONE; PSYCHIATRY; RECEPTORS, ESTROGEN; RECURRENCE; SYNAPTIC TRANSMISSION; WOMEN'S HEALTH;

EID: 0031893863     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatrie Press; 1996
2. Stahl SM. Reproductive hormones as adjuncts to psychotropic medication. Directions in Psychiatry. New York, NY: Hatherleigh Company. 1997;18: 303-314
3. Janowsky DS, Halbreich U, Rausch J. Association among ovarian hormones, other hormones, emotional disorders and neurotransmitters. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996:85-106
4. Sherwin BB. Menopause: early aging and elderly women. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996:225-240
5. Stahl SM. Essential Psychopharmacology. New York, NY: Cambridge University Press; 1996
6. Stahl SM. Mechanics of action of serotonin selective reuptake inhibitors: serotonin receptors and pathways mediate therapeutic effects and side effects (mechanism of action of SSRIs). J Affect Disord. In press
7. Best NR, Rees MP, Barlow J. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 1992;17:87-93
8. McEwen BS, Parsons B. Gonadal steroid action on the brain: neurochemistry and neuropharmacology. Annual Review of Pharmacology and Toxicology 1987;22:555-598
9. Kendall DA, Stancel GM, Enna SJ. The influence of sex hormones on antidepressant induced alterations in neurotransmitter receptor binding. J Neurosci 1982;2:354-360
10. Biegon A, McEwen BS. Modulation by estradiol of serotonin receptors in brain. J Neurosci 1982;2:199-205
11. Biegon A, Reches A, Snyder L, et al. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 1983;32:2015-2021
12. Fludder MJ, Tonge SR. Variations in concentrations of monoamines in eight regions of rat brain during estrous cycle: a basis for interactions between hormones and psychotropic drugs. J Pharm Phamiacol 1975;27:39-42
13. Halbreich U, Rojansky N, Palter S, et al. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1993;37:434-441
14. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:2637-2641
15. Fillit H, Weinreb H, Chlost I. Observations in a preliminary open trial of estradiol therapy for senile dementia of the Alzheimers type. Psychoneuroendocrinology 1986;11:337-345
16. Luine VN, Hearns M. Spatial memory deficits in aged rats: contributions of the cholinergic system assessed by ChAT. Brain Res 1990;523:321-324
17. Stahl SM. Estrogen makes the brain a sex organ [BRAINSTORMS]. J Clin Psychiatry 1997;58:421-422
18. Yang NN, Venugopalan M, Hardikar S, et al. Identification of an estrogen response element activated by metabolites of 17-beta-estradiol and raloxifene. Science 1996;273:1222-1225
19. Lauber AH, Romano GJ, Pfaff DW. Sex differences in estradiol regulation of progestin receptor mRNA in rat mediobasal hypothalamus as demonstrated by in situ hybridization. Neuroendocrinology 1991;53:608-613
20. Lauber AH, Romano GJ, Mobbs CV. Estradiol regulation of estrogen receptor messenger RNA in rat mediobasal hypothalamus: an in situ hybridization. J Neuroendocrinol 1990;2:605-611
21. McEwen BS. Nongenomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991;12:141-147
22. O'Malley BW, Means AR. Female steroid hormone and target cell nuclei. Science 1993;183:610-620
23. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-343
24. Holst J, Backstrom T, Hammerback S. Progestin addition during oestrogen replacement therapy: effects on vasomotor symptoms and mood. Maturitas 1989;11:13-20
25. Yen SSC, Jaffe RB, eds. Reproductive Endocrinology, Physiology, Pathophysiology and Clinical Management. Philadelphia, Pa: Saunders; 1986
26. Woolley CS, Gould E, Frankfurt M. Naturally occurring fluctuations in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990;10:4035-4039
27. McEwen BS. Influence of gonadal steroids on the brain. In: Syllabus and Proceedings Summary of the 1996 annual meeting of the American Psychiatric Association; May 4-9, 1996; New York, NY. No. 5D:285-286
28. Ditkoff EC, Crary WG, Cristo M, et al. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991; 78:991-995
29. Stahl SM. Sex therapy in psychiatric treatment has a new partner: reproductive hormones [BRAINSTORMS]. J Clin Psychiatry 1997;58:468-469
30. Klaiber EL, Broverman DM, Vogel W, et al. Estrogen therapy for severe persistent depression in women. Arch Gen Psychiatry 1979;36:550-554
31. Oppenheim G. Estrogen in the treatment of depression: neuropharmacological mechanisms. Biol Psychiatry 1983;18:721-725
32. Shapira B, Oppenheim G, Zohar J. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry 1985; 20:576-579
33. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992;80:30-36
34. Kindler S, Sasson Y, Cohen RE, et al. The role of oestrogen augmentation in females with refractory depression. In: Nolen WA, Zohar J, Roose SP, et al, eds. Refractory Depression: Current Strategies and Future Directions. Chichester, England: John Wiley & Sons; 1994:159-162
35. Culberg J. Mood changes and menstrual symptoms with different gestagen/ estrogen combinations: a double-blind comparison with a placebo. Acta Psychiatr Scand 1972;236:1-86
36. Dennerstein L, Burrows GD, Hyman GJ. Hormone therapy and affect. Maturitas 1979;1:247-259
37. Depression and oral contraception [editorial]. BMJ 1970;4:127-128
38. Oppenheim G. Estrogen in the treatment of depression: neuropharmacological mechanisms. Arch Gen Psychiatry 1986;43:569-573
39. Roy-Byme P, Rubinow DR, Gold PW. Possible antidepressant effect of oral contraceptives: case report. J Clin Psychiatry 1984;45:350-352
40. Schneider MA, Brotherton PL, Hailes J. The effect of exogenous oestrogens on depression in menopausal women. Med J Aust 1977;2: 162-165
41. Sherwin B, Gelfand M. Sex steroids and affect in the surgical menopause: a double blind cross over study. Psychoneuroendocrinology 1985;10: 325-335
42. Billings EL, Brown JB, Billings JJ. Symptoms and hormonal changes accompanying ovulation. Lancet 1972;1:282-284
43. Jensvold MF. Nonpregnant reproductive age women, I: the menstrual cycle and psychopharmacology. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996:139-170
44. Garvey MJ, Tollefson GD. Postpartum depression. J Reprod Med 1984;29: 113-116
45. Parry B. Reproductive related depressions in women: phenomena of hormonal kindling? In: Hamilton JA, Harberger PN, eds. Postpartum Psychiatric Illness: A Picture Puzzle. Philadelphia, Pa: University of Pennsylvania Press; 1992:200-218
46. Jensvold MF. Nonpregnant reproductive age women, II: exogenous sex steroid hormones and psychopharmacology. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996;171-190
47. Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977;34:145-149
48. Weissman MM, Leaf PJ, Livingston-Bruce M. The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment. Am J Psychiatry 1988;145:815-819
49. Weissman MM. Epidemiology of major depression in women. In: Syllabus and Proceedings Summary of the 1996 annual meeting of the American Psychiatric Association; May 4-9, 1996; New York, NY. No. 5C:285
50. DeGroot L, Besser G, Marshall J. Endocrinology. Philadelphia, Pa: Saunders; 1989
51. Jensvold MF, Plaut VC, Rojansk N, et al. Sexual side effects of psychotropic drugs in women and men. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996:323-370
52. Dawkins K, Potter WZ. Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women. Psychopharmacol Bull 1991;27:417-426
53. Yonkers KA, Kando JC, Cole JO, et al. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1991;149:587-595
54. Hamilton KA, Yonkers KA. Sex differences in pharmacokinetics of psychotropic medications, physiological basis for effects and effects on selected psychotropics. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996:11-72
55. Majewska MD. Sex differences in brain morphology and pharmacodynamics. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996:73-84
56. Harrison W, Brumfield MA. Psychopharmacological drug testing in women. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996:371-392
57. Hamilton JA, Grant M, Jensvold MF. Sex and treatment of depressions: when does it matter? In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996:240-260
58. Grady D, Rubin SM. Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117: 1016-1037
59. Belchetz PE. Hormonal treatment of postmenopausal women. New Engl J Med 1994;330:1062-1071
60. Jones KP. Estrogens and progestins: what to use and how to use it. Clin Obstet Gynecol 1992;35:871-883
61. Sarrel PM. Estrogen replacement therapy. Obstet Gynecol 1988;72:2S-5S
62. Grimes DA, ed. Women's health in the perimenopause. Contraception Report 1993;4:5-10
63. Halbreich U. Hormonal replacement therapy, mood and cognition. In: Syllabus and Proceedings of the 149th Annual Meeting of the American Psychiatric Association; May 4, 1996; New York, NY. No. 5E:286
64. Preskorn SH. Antidepressants, gender and treatment outcome. In: Syllabus and Proceedings of the 149th Annual Meeting of the American Psychiatric Association; May 4, 1996; New York, NY. No. 5B:285
65. Burt VK. New Approaches to the management of perimenopausal depression. In: Syllabus and Proceedings of the 149th Annual Meeting of the American Psychiatric Association; May 7, 1996; New York. NY. No. 23B: 307